Elderly population needs new definition to inform treatment decisions

Expert care is needed for elderly haematology patients

Polygenic susceptibility: What might it tell us?

Engineering of polymeric nanoparticles for medical applications

Making sense of the expanding armoury of treatment options for the less fit CLL patient

Treatment decision making, screening and palliative care

Molecular imaging using PET-CT and personalised therapy with neuroendocrine tumours

The molecular basis of cancer

Choosing the right treatment for each patient: The emergence of personalised healthcare in non-small cell lung cancer

The role of molecular pathways in therapeutic response and outcomes in breast cancer

Traditional and personalised models of therapy in gastrointestinal and endocrine tumours: the role of histological and clinical markers

Future perspectives: realising the potential of personalised healthcare in gynaecological cancer